GPT-5.5 Bio Bug Bounty

OpenAI has quietly rolled out a new flavor of its bug bounty program, this one aimed squarely at GPT-5.5 and the narrow but terrifying question of whether the model can be coaxed into helping with biological weapons research. Instead of the usual hunt for prompt injection or data leaks, researchers are being invited to stress-test the model's refusal behavior around pathogen synthesis, toxin production, and other biosecurity red lines.

This isn't a random gesture. Frontier labs have spent the last two years watching language models get better at chemistry, virology, and lab protocol reasoning, which is great for drug discovery and genuinely alarming when someone asks the wrong question the right way. GPT-5.5 apparently crossed some internal capability threshold that made OpenAI nervous enough to bring in outside eyes rather than rely solely on internal red-teamers who, let's be honest, start to think alike after a while.

What makes this bounty different from the typical jailbreak hunt is the stakes attached to a single successful bypass. Finding a clever way to get a chatbot to write malware is bad. Finding a clever way to get it to walk through synthesis steps for a bioagent is a different category of bad, and OpenAI seems to be treating it that way by carving out a dedicated track rather than lumping it in with general safety reports.

The move also fits a pattern taking shape across the industry: labs increasingly outsource the scariest parts of safety testing to crowds of specialists who have no incentive to be polite about failures. Anthropic has run similar biosecurity-focused evaluations, and Google DeepMind has talked publicly about dangerous capability thresholds for its own models. OpenAI joining that club with a paid, structured program suggests the conversation has moved past PR statements into something closer to standard practice, at least for the handful of labs that can afford to run one.

Still, a bounty program is only as good as what happens after someone finds the hole. Details on remediation timelines, payout structure, and whether findings get shared with other labs remain thin in what OpenAI has published so far. That gap matters more than the announcement itself.